Factor XI deficiency is a very rare autosomal recessive bleeding disorder. In many cases, the disorder is identified after trauma or surgery because otherwise, patients do not experience any spontaneous bleeding or other specific symptoms [1] [2] [3] . Patients are particularly prone to bleeding during surgery or trauma which involves the oral mucosa, nose or genitourinary tract whose sites are rich in fibrinolytic activators [4] [5] [6] . Factor XI deficiency occurs in approximately 1:1,000,000 Ashkenazi Jews [3, 7, 8] . Orthognathic surgery is usually associated with a high bleeding risk in patients with factor XI deficiency.
Therefore, great care must be taken when treating patients with such bleeding disorders.
Hemoglobin measurement in patients undergoing orthognathic surgery is one of the most significant examinations. Based upon patient's degree of anemia, anesthesiologists decide whether or not a blood transfusion is indicated. In the case of hemorrhagic diseases such as hemophilia, such decisions must be made with extra care. This might require frequent and repeated invasive blood sampling. However, it is disadvantageous because of the time commitment that it requires.
Therefore, continuous monitoring is more useful in cases in which there is heavy bleeding such as during orthognathic surgery, or in patients with hemophilia who have a tendency to hemorrhage [9] . The Masimo Radical 7 is a noninvasive device capable of continuously measuring hemoglobin (SpHb). The usage of this device during surgery allows proper and timely treatment.
There are few reports that address the management of patients with bleeding disorders who are undergoing orthognathic surgery [10] [11] [12] . Here, we present effective perioperative management using the SpHb and rotation thromboelastometry (ROTEM TM ) during orthognathic surgery of patients with Factor XI deficiency. The decision was made to operate on the patient using both the SpHb and rotation thromboelastometry for effective perioperative management.
During surgery, the patient's ECG, noninvasive blood pressure, percutaneous oxygen saturation, temperature, and arterial line were actively monitored. Intravenous thiopental 175.0 mg was used to induce anesthesia. The patient was intubated nasally after the administration of cisatracurium 12.0 mg. Anesthesia was maintained with 5-6% desflurane, 50% nitrous oxide and oxygen. The patient's vital signs were stable throughout the procedure (Fig 1) . The surgery time was total 250 minutes and the anesthesia time was 300 minutes. There was a total of 560 ml blood loss, and 500 ml of urine output. The patient's Hb levels were continuously checked through the SpHb values (Fig. 2) . Four units of fresh frozen plasma (FFP) and two autologous units of blood (360 ml) were and intrinsically activated test (INTEM) (Fig. 3) .
After surgery but before the patient's discharge, her bleeding tendency was investigated using coagulation tests including aPTT. Seven days after surgery, aPTT was slightly elevated at 48.4 seconds. The patient was discharged without any complications.
DISCUSSION
Factor XI deficiency (hemophilia C) is a rare disease.
As of 2005, there were only ten registered patients with factor XI deficiency in Korea, accounting for 0.5% of the population. This figure likely underestimates the true number of patients because those who with factor XI deficiencies are not diagnosed unless they experience trauma or undergo surgery. The recommended method for managing factor XI deficiency during surgery in which a large amount of bleeding is expected is with FFP transfusion [13, 14] . An antifibrinolytic drug such as tranexamic acid has also been reported to be highly effective in reducing bleeding [1, 3, 15] . There is also literature suggesting that administering factor VII during surgery is successful, except that it also increases the risk of thrombosis [16] [17] [18] .
The maxillofacial region is rich in vasculature. It is often difficult to control bleeding during orthognathic surgery and tends to be complicated by hemorrhage more often than do other types of surgery [19] . Prior studies have suggested that orthognathic surgery involves an average of 436.1 ml blood loss inside the oral cavity and takes an average of 196.9 minutes in operation time [20] .
The amount of blood loss is directly related to the operation time and degree of intervention. The actual amount of bleeding often exceeds the expected amount;
therefore, reserve blood should be prepared. Sometimes, even autologous transfusion becomes necessary.
A skilled surgical technique can significantly reduce blood loss. In addition, medications such as tranexamic acid and desmopressin can also be used [21] . In the present case, the patient lost 560.0 ml of blood during a 350-minutes operation. The patient was transfused with four units of FFP and two units of autologous blood. We also used tranexamic acid one day before surgery to prevent bleeding as much as possible.
Since orthognathic surgery is particularly associated with excess bleeding, the patient was carefully monitored throughout the procedure using both 
